These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2392503)

  • 61. Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase.
    Lowe JA; Archer RL; Chapin DS; Chen JB; Helweg D; Johnson JL; Koe BK; Lebel LA; Moore PF; Nielsen JA
    J Med Chem; 1991 Feb; 34(2):624-8. PubMed ID: 1995886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.
    Iyo M; Bi Y; Hashimoto K; Inada T; Fukui S
    Eur J Pharmacol; 1996 Sep; 312(2):163-70. PubMed ID: 8894591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors.
    Yamamoto T; Miyamoto K; Ueki S
    Jpn J Pharmacol; 1987 Feb; 43(2):165-71. PubMed ID: 3573424
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
    Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alterations in the binding of the phosphodiesterase inhibitor, rolipram, after transient ischemia in the gerbil brain.
    Asanuma M; Ogawa N; Hirata H; Kondo Y; Nishibayashi S; Yamamoto M; Mori A
    Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):279-85. PubMed ID: 8122028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain.
    Kehr W; Debus G; Neumeister R
    J Neural Transm; 1985; 63(1):1-12. PubMed ID: 4031844
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
    O'Donnell JM; Frith S
    Pharmacol Biochem Behav; 1999 May; 63(1):185-92. PubMed ID: 10340540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    Liang L; Beshay E; Prud'homme GJ
    Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of the phosphodiesterase inhibitor rolipram on the acoustic startle response in rats.
    Kehne JH; Boulis NM; Davis M
    Psychopharmacology (Berl); 1991; 105(1):27-36. PubMed ID: 1660609
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
    Hirose R; Manabe H; Nonaka H; Yanagawa K; Akuta K; Sato S; Ohshima E; Ichimura M
    Eur J Pharmacol; 2007 Nov; 573(1-3):93-9. PubMed ID: 17658510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex.
    Donaldson J; Brown AM; Hill SJ
    Biochem Pharmacol; 1988 Feb; 37(4):715-23. PubMed ID: 2829922
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.
    Souness JE; Scott LC
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):389-95. PubMed ID: 8387267
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart.
    Némoz G; Moueqqit M; Prigent AF; Pacheco H
    Eur J Biochem; 1989 Oct; 184(3):511-20. PubMed ID: 2553394
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 May; 305(2):565-72. PubMed ID: 12704225
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
    Zhang HT; Huang Y; Mishler K; Roerig SC; O'Donnell JM
    Psychopharmacology (Berl); 2005 Oct; 182(1):104-15. PubMed ID: 16010541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
    Gordeladze JO
    Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The influence of rolipram on the central serotoninergic system.
    Przegalínski E; Bigajska K; Lewandowska A
    Pharmacopsychiatria; 1981 Sep; 14(5):162-6. PubMed ID: 7291300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.